Âé¶¹´«Ã½

Apotex Can't Sink Amgen's IP Suit Over Drugs To Aid Chemo

By Danielle Nichole Smith ( April 5, 2019, 8:54 PM EDT) -- Amgen can move forward with allegations that Apotex infringed a patent covering its chemotherapy-easing drugs Neupogen and Neulasta after a Florida federal judge ruled that it was too early to find the suit was barred by litigation over a related patent....

Âé¶¹´«Ã½360 is on it, so you are, too.

A Âé¶¹´«Ã½360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Âé¶¹´«Ã½360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Âé¶¹´«Ã½360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login